(reprint from Business Wire, published: July 22, 2022) Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody…

July is UV Safety Awareness Month, and with so much time spent outdoors, practicing sun safety should be top of…

Many skin cancer survivors develop high anxiety regarding sun exposure and being outside, especially during summer. How can active coping…

by Mara Klecker It’s natural and common to worry about how a parent’s cancer diagnosis and treatment is going to…

Cancer Survivorship begins the moment you learn of your diagnosis and continues long after treatment. And thanks to medical advances,…

by Mara Klecker Steve Banks doesn’t often bring up his melanoma diagnosis during a first date, though he’s always forthright…

(reprint from Biospace, published: Jun 03, 2022) Immunocore announcesclinical trial collaboration with Sanofito evaluate Sanofi’s product candidate SAR444245, non-alpha IL-2,in combination with KIMMTRAK® in patients with metastatic cutaneous…

(reprint from Targeted Oncology, published: Jun 05, 2022) Adjuvant Pembrolizumab Significantly Improves DMFS and RFS in Patients with Stage II…

Dr. Zeynep Eroglu is a medical oncologist at Moffitt Cancer Center in Florida. Dr. Eroglu’s research interests are translational and…

TISSUE IS THE ISSUE AIM at Melanoma’s major research initiative—the International Melanoma Tissue Bank Consortium (IMTBC)—is the first of its…